Literature DB >> 3290917

Incidence, prevalence and risk factors for non-insulin-dependent diabetes mellitus.

R G Nelson1, J E Everhart, W C Knowler, P H Bennett.   

Abstract

Non-insulin-dependent diabetes is a worldwide disease. In the United States nearly 10 million persons are affected and the prevalence is increasing. Considerable advances in the understanding of the pathogenesis and determinants of non-insulin-dependent diabetes have occurred in recent years. Genetic and environmental determinants are associated with the development of diabetes, but the mode of inheritance of the genetic determinants is unknown. Obesity, particularly if it is centrally distributed and of long duration, is the most prominent environmental risk factor for non-insulin-dependent diabetes. Although it has long been suspected as an etiological factor, evidence that physical activity is a predictor of the disease is now emerging. The adoption of a western lifestyle and improvements in socioeconomic conditions are at least partially responsible for the very high rates of diabetes among several ethnic and racial groups, although the specific components of these changes that contribute to development of non-insulin-dependent diabetes are still uncertain. Other factors that worsen insulin resistance are likewise predictive of the development of disease. An understanding of the risk factors for non-insulin-dependent diabetes may lead to more specific intervention, and possibly to prevention of this disease.

Entities:  

Mesh:

Year:  1988        PMID: 3290917

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  8 in total

1.  Trends in mortality from diabetes mellitus in Taiwan, 1960-1988.

Authors:  R S Lin; W C Lee
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

Review 2.  Results of the DCCT trial. Implications for managing our patients with diabetes.

Authors:  G Worrall
Journal:  Can Fam Physician       Date:  1994-11       Impact factor: 3.275

3.  Cardiovascular disease in Navajo Indians with type 2 diabetes.

Authors:  W Hoy; A Light; D Megill
Journal:  Public Health Rep       Date:  1995 Jan-Feb       Impact factor: 2.792

4.  Longitudinal Trends in the Prevalence of Diabetes Mellitus in an Urban Emergency Department.

Authors:  Sarah A Sterling; Alan E Jones; Robert D Cox
Journal:  South Med J       Date:  2016-04       Impact factor: 0.954

5.  Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial.

Authors:  Maria Paile-Hyvärinen; Kristian Wahlbeck; Johan G Eriksson
Journal:  BMC Fam Pract       Date:  2003-05-14       Impact factor: 2.497

6.  Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial.

Authors:  Ruiying Kang; Yan He; Yuxiang Yan; Zhiwu Li; Yeqing Wu; Xiaojuan Guo; Zhigang Liang; Jun Jiang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-27       Impact factor: 2.570

7.  Diabetes Risk Score in a Young Student Population in Jordan: A Cross-Sectional Study.

Authors:  Abdel-Ellah Al-Shudifat; Amjad Al-Shdaifat; Ahmad Ali Al-Abdouh; Mohammad Ibrahim Aburoman; Sara Mohammad Otoum; Amro Ghaleb Sweedan; Ibrahim Khrais; Ibrahim Hisham Abdel-Hafez; Asgeir Johannessen
Journal:  J Diabetes Res       Date:  2017-04-29       Impact factor: 4.011

8.  Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial.

Authors:  Maria Paile-Hyvärinen; Kristian Wahlbeck; Johan G Eriksson
Journal:  BMC Fam Pract       Date:  2007-06-15       Impact factor: 2.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.